🎁 Code: '500freebie' - Spend $500, add an item from Other Peptides, get it for free (exclusions apply)
🚚 Free Shipping when you spend $350 or more
Melanotan I is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), a peptide involved in various biological processes, particularly in regulating pigmentation. Developed as a synthetic peptide, Melanotan I has been extensively studied for its ability to influence pigmentation processes in biological systems. Its primary application has been in promoting pigmentation, but research has also suggested other potential uses.
Melanotan I, also known as afamelanotide, is a synthetic peptide developed as an analogue of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). This peptide was designed to mimic the effects of α-MSH, particularly its ability to stimulate melanin production through activation of the melanocortin 1 receptor (MC1R). The amino acid sequence of Melanotan I is highly similar to that of α-MSH, with specific modifications to enhance its stability and receptor binding efficiency.
The amino acid sequence of Melanotan I is as follows: Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2. Several key features of this structure contribute to its function:
These structural modifications make Melanotan I more resistant to enzymatic breakdown, allowing it to maintain its activity over a longer duration and making it an effective agent for research into pigmentation and other physiological processes influenced by melanocortin receptor activation.
Cryo-electron microscopy (cryo-EM) has been essential in elucidating the interactions between Melanotan I and its target receptor, the melanocortin 1 receptor (MC1R). This advanced imaging technique allows for visualization of the peptide-receptor complex at near-atomic resolution, providing detailed insights into the binding dynamics and structural changes induced by Melanotan I.
Cryo-EM studies of Melanotan I have revealed how its modified structure enhances its binding to MC1R. The acetylation at the N-terminus and the substitution of norleucine (Nle) for methionine contribute to a stable interaction with the receptor, positioning the peptide optimally within the receptor’s binding pocket. This stable binding is crucial for the activation of MC1R, which leads to increased melanin production, contributing to pigmentation.
These studies have also shown how the specific amino acid interactions within the receptor binding site are critical for the efficacy of Melanotan I. For example, the D-phenylalanine (D-Phe) residue plays a key role in securing the peptide within the receptor, while the amidated C-terminus enhances receptor activation by stabilizing the active conformation of MC1R.
Cryo-EM imaging has provided valuable insights into the conformational changes that occur in MC1R upon binding with Melanotan I. These changes are essential for initiating the signaling pathways that result in melanin synthesis. Understanding these structural dynamics is important for developing new therapeutic approaches that target melanocortin receptors, potentially leading to advances in treatments for pigmentation disorders and other related conditions.
By revealing the detailed interactions between Melanotan I and MC1R, cryo-EM studies support ongoing efforts to optimize peptide design for specific therapeutic applications, enhancing the potential of Melanotan I and related peptides in clinical research.
Melanotan I functions by mimicking the natural effects of α-MSH, binding to melanocortin receptors, with a particular affinity for the melanocortin 1 receptor (MC1R). MC1R is a receptor that plays a key role in the regulation of pigmentation by influencing melanin production within cells known as melanocytes.
Upon binding to MC1R, Melanotan I triggers a cascade of intracellular signals, including the activation of cyclic AMP (cAMP), which leads to an increase in melanin synthesis. This process results in enhanced pigmentation, offering a protective response that is typically observed in biological systems exposed to various environmental factors.
The pharmacokinetics of Melanotan I includes its absorption, distribution, and duration of action within biological systems. Once introduced, Melanotan I is absorbed and distributed across various tissues, where it interacts with melanocortin receptors. The peptide’s synthetic design offers enhanced stability, allowing it to remain active for a longer period compared to its natural counterpart, α-MSH. This extended duration of action contributes to sustained pigmentation effects in biological models.
Melanotan I is widely recognized for its role in enhancing pigmentation, making it a subject of interest in various biological and cosmetic research studies. Studies have shown that Melanotan I can effectively promote pigmentation, producing a noticeable darkening effect in biological tissues. This ability to influence pigmentation is particularly relevant in studies where traditional methods of pigmentation enhancement are less effective or require prolonged exposure to external factors.
Melanotan I offers several advantages over traditional pigmentation methods:
Beyond its role in pigmentation, Melanotan I is being explored for its potential applications in various biological research contexts:
Ongoing research continues to explore the broader applications of Melanotan I in various scientific fields. The peptide’s stability and specificity make it a candidate for further studies aimed at understanding its full range of biological effects. Additionally, Melanotan I’s potential for influencing pigmentation in diverse models suggests avenues for future exploration in areas such as pigmentary research and beyond.
Melanotan I and Melanotan II are both analogues of α-MSH, but they differ in their biological effects. While Melanotan I is more selective for the MC1R receptor and is primarily studied for its effects on pigmentation, Melanotan II interacts with multiple melanocortin receptors, leading to a broader range of biological effects. This distinction makes Melanotan I more suited for studies focused specifically on pigmentation without introducing additional variables.
In comparison to other peptides used in pigmentation research, Melanotan I offers unique benefits due to its stability and targeted action. Peptides like afamelanotide, another melanocortin analogue, have been developed for specific research purposes, but Melanotan I remains a versatile option for general studies of pigmentation and related biological processes.
As research into Melanotan I progresses, its potential applications continue to expand. Studies may explore its role in pigmentation-related research, as well as its broader applications in understanding melanocortin receptor interactions. The peptide’s specific interaction with MC1R also suggests potential for studying receptor dynamics and signal transduction in pigmentation pathways.
Despite its documented benefits, further research is needed to fully understand the long-term implications of Melanotan I use in various models. Studies focusing on the peptide’s effects across different biological systems, its stability under varying conditions, and its interactions with other molecules will be crucial in optimizing its use in research.
Melanotan I is a versatile peptide with significant potential in pigmentation research and beyond. Its ability to promote pigmentation through targeted biological pathways, combined with its stability and specificity, makes it a valuable tool for researchers exploring various aspects of pigmentation and melanocortin receptor interactions. Continued research is essential to fully understand its capabilities and optimize its applications in scientific studies.
For researchers looking to explore Melanotan I, Polaris Peptides offers high-quality Melanotan for sale for various research applications. Ensure your studies are supported by reliable and effective materials from a trusted source.
Did you like this article? We think you’ll also enjoy our article on GHK-Cu. Read more here.
Melanotan I is a synthetic peptide that mimics alpha-melanocyte-stimulating hormone (α-MSH), promoting pigmentation by stimulating melanocortin receptors, particularly MC1R.
Melanotan I is more selective for MC1R, primarily affecting pigmentation, while Melanotan II has broader effects due to its interaction with multiple melanocortin receptors.
Melanotan I offers a controlled method for enhancing pigmentation, with long-lasting effects and reduced need for external exposure, making it a valuable tool in various research settings.
While Melanotan I is generally well-tolerated in research models, considerations include its stability, dosage, and potential interactions with other compounds used in studies.
At Polaris Peptides, we are dedicated to supporting the scientific community by supplying high-quality peptides designed exclusively for research and development endeavors of professionals. Our products are crafted for investigative purposes and are not suitable for direct human consumption or consumers, nor are they intended for clinical or therapeutic use. We uphold a strict policy to ensure our peptides are recognized distinctly from prescription medications as an entity committed to research.
Polaris Peptides is a chemical supplier. Polaris Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Polaris Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Products
Legal
Customer Service
To contact management, please email *@*************es.com
You may also call or leave us a message at (800) 273-9462. Please note during busy times (such as Black Friday) we may not be able to answer all calls. Please leave a voicemail with all necessary details or email us at our support email.
© 2025 Polaris Peptides. All Rights Reserved.
Discount Applied Successfully!
Your savings have been added to the cart.
Join our Polaris Insiders program to get rewarded for loyalty with exclusive deals, news about upcoming products, and more.
You must be 18 years old or older in order to access our website. Please verify your age.